The aim of this study was to determine the serum mannose-binding lectin (MBL) levels and the frequency of MBL gene polymorphisms in infants with neonatal sepsis. Between January 2008 and January 2010, ...

Epidemiology and Infection, Vol. 142, No. 10 (OCTOBER 2014), pp. 2195-2206 (12 pages) Several studies have evaluated the association between mannose-binding lectin (MBL) polymorphisms and sepsis.

We analysed 131 stem cell recipients to evaluate the influence of MBL on TRM, infection, and acute GVHD (aGVHD) in the Allo-SCT setting. Blood for MBL pheno- and genotypes was collected pre-transplant ...

Current use and attitudes toward the use of information technologies in health care among cancer patients. This is an ASCO Meeting Abstract from the 2014 ASCO Annual Meeting I. This abstract does not ...

The contribution of mannose-binding lectin (MBL) to protection from malaria was assessed by comparing plasma concentrations of MBL and the frequency of MBL gene polymorphisms in groups of Gabonese ...

Chronic liver disease is a major complication of cystic fibrosis (CF) and factors other than the deletion of ΔF508 (which causes CF) may control the development of liver damage. In May Journal of ...

The humoral arm of innate immunity consists of numerous pattern recognition molecules, such as mannose-binding lectin (MBL) and pentraxin 3 (PTX3). Humoral pattern recognition molecules persist as the ...

Figure 1: Mannose-binding lectin (blue strands) can bind to sites on the SARS-Cov-2 spike protein on the cell membrane. One of the most striking features of the SARS-CoV-2 pandemic is that across all ...

Please note that if you are outside North America the embargo for Lancet Press Material is 0001 hours UK time Friday 24th August 2001. Low concentrations of the blood protein mannose-binding lectin ...

The lectin pathway is the third pathway in the complement cascade, discovered after the classical and alternative pathways. It more closely resembles the classical pathway due to similar binding ...

Scientists at the Wyss Institute at Harvard University have engineered the human blood opsonin protein known as FcMBL, or Fc-mannose binding lectin, which was originally developed as a broad-spectrum ...